HEB $2 Monday HUGE Conference Call
CC Summary:
Hemispherics are stand alone financed now for five years ( a 18.3MM private finacing on very favourable terms was just announced today, and their 28MM revolving credit facility remains operational), and 'they had 6 million in cash to use before this new offering took place. 3 million of the warrants have only a 45-day strike price of 1.10. Obviously those are in place in case Ampligen receives approval for CFS treatment.' (RonnieD}
They expect to get FDA approval on their main drug (Ampligen) shortly, are well in advanced stages of trials in Japan for this and others, they have a very wide range of applications for their drugs including MS and Chronic Fatigue Syndrome (a $90Bn drain on the U.S. economy per annum), and expect to partner with a heavyweight this year on the marketing and delivery side.
The stock is breaking out to new highs in reaction to the successful financing, and new business opportunities on the near horizon.
The whole thing is being guided by the person who pioneered Interferon out of Johns Hopkins, the CEO himself.
He says today:
'We have emerged as a very serious player in the influenza space. We have emerged as a serious player in the vaccine space."
We are focusing on PANDEMIC APPLICATIONS....
"We see the current woldwide influenza problem as a major, major opportunity for Hemispherics in catastrophic applications... we are a serious,
AI
